Evidence map›Paper›PMID 34624070›Full record

ArticlePloS one2021

Prediction of recurrent stroke among ischemic stroke patients with atrial fibrillation: Development and validation of a risk score model.

Beom Joon Kim, Keon-Joo Lee, Eun Lyeong Park, Kanta Tanaka, Masatoshi Koga, Sohei Yoshimura, Ryo Itabashi, Jae-Kwan Cha, Byung-Chul Lee, Hisanao Akiyama and 6 more

Open access · goldAbstract readMulticenter StudyValidation Study
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 2 countries.

Beom Joon KimDepartment of Neurology and Cerebrovascular Center, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-si, Republic of Korea.ORCID 0000-0002-2719-3012
Keon-Joo LeeDepartment of Neurology and Cerebrovascular Center, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-si, Republic of Korea.
Eun Lyeong ParkDepartment of Biostatistics, College of Medicine, Korea University, Seoul, Republic of Korea.
Kanta TanakaDivision of Stroke Care Unit, National Cerebral and Cardiovascular Center, Suita, Japan.ORCID 0000-0002-3291-5083
Masatoshi KogaDepartment of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.
Sohei YoshimuraDepartment of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.
Ryo ItabashiDepartment of Stroke Neurology, Kohnan Hospital, Sendai, Japan.
Jae-Kwan ChaDepartment of Neurology, Dong-A University Hospital, Busan, Republic of Korea.
Byung-Chul LeeDepartment of Neurology, Hallym University Sacred Heart Hospital, Anyang, Korea.ORCID 0000-0002-3885-981X
Hisanao AkiyamaDivision of Neurology, Department of Internal Medicine, St Marianna University of Medicine, Kawasaki, Japan.ORCID 0000-0003-4491-6064
Yoshinari NagakaneDepartment of Neurology, Kyoto Second Red Cross Hospital, Kyoto, Japan.
Juneyoung LeeDepartment of Biostatistics, College of Medicine, Korea University, Seoul, Republic of Korea.
Kazunori ToyodaDepartment of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.
SAMURAI Study Investigators
Hee-Joon BaeDepartment of Neurology and Cerebrovascular Center, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-si, Republic of Korea.
CRCS-K Investigators
National Cerebral and Cardiovascular Center · JPSeoul National University Bundang Hospital · KRKorea University · KRDong-A University Hospital · KRHallym University Sacred Heart Hospital · KRKohnan Hospital · JPKyoto first Red Cross hospital · JPSt. Marianna University School of Medicine · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is currently no validated risk prediction model for recurrent events among patients with acute ischemic stroke (AIS) and atrial fibrillation (AF). Considering that the application of conventional risk scores has contextual limitations, new strategies are needed to develop such a model. Here, we set out to develop and validate a comprehensive risk prediction model for stroke recurrence in AIS patients with AF.

methodsAIS patients with AF were collected from multicenter registries in South Korea and Japan. A developmental dataset was constructed with 5648 registered cases from both countries for the period 2011‒2014. An external validation dataset was also created, consisting of Korean AIS subjects with AF registered between 2015 and 2018. Event outcomes were collected during 1 year after the index stroke. A multivariable prediction model was developed using the Fine-Gray subdistribution hazard model with non-stroke mortality as a competing risk. The model incorporated 21 clinical variables and was further validated, calibrated, and revised using the external validation dataset.

resultsThe developmental dataset consisted of 4483 Korean and 1165 Japanese patients (mean age, 74.3 ± 10.2 years; male 53%); 338 patients (6%) had recurrent stroke and 903 (16%) died. The clinical profiles of the external validation set (n = 3668) were comparable to those of the developmental dataset. The c-statistics of the final model was 0.68 (95% confidence interval, 0.66 ‒0.71). The developed prediction model did not show better discriminative ability for predicting stroke recurrence than the conventional risk prediction tools (CHADS2, CHA2DS2-VASc, and ATRIA).

conclusionsNeither conventional risk stratification tools nor our newly developed comprehensive prediction model using available clinical factors seemed to be suitable for identifying patients at high risk of recurrent ischemic stroke among AIS patients with AF in this modern direct oral anticoagulant era. Detailed individual information, including imaging, may be warranted to build a more robust and precise risk prediction model for stroke survivors with AF.

Indexed as

Atrial FibrillationIschemic StrokeRecurrenceAgedAged, 80 and overFemaleHumansJapanMaleMiddle AgedRegistriesRepublic of KoreaRisk AssessmentRisk Factors

Identifiers

PMID34624070
PMCPMC8500448
OpenAlexW3204631988

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.